Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FES PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
NCT05982496Phase 2Recruiting
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Jun 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in breast cancer, sponsored by Vita-Salute San Raffaele University. Primary endpoint: Sensitivity of FES PET/MRI in detecting macrometastatic axillary lymph nodes at Day 50. Started Jun 2026; status: recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05982496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05982496.